Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 30, 2026 07:30 ET | Source: Marvel Biosciences Corp.

Marvel Biosciences Secures Alberta Innovates Funding to Support the Phase I Testing of MB-204

Marvel Biosciences secures $600,000 in non-dilutive funding from Alberta Innovates to support Phase I clinical trials of its autism-focused patented MB-204
March 25, 2026 07:30 ET | Source: Marvel Biosciences Corp.

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204

Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204, lead asset discovery, a patented neuroactive adenosine A2A antagonist
March 16, 2026 08:15 ET | Source: Osisko Development Corp.

Osisko Development Announces Inclusion in the GDXJ

MONTREAL, March 16, 2026 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or the "Company") is pleased to announce its inclusion in the VanEck Junior Gold...
March 12, 2026 10:45 ET | Source: Equity Insider

Mining Investment Surges as Global Conflicts Induce Further Gold Price Rally and Exploration

VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) -- EquityInsider.com Sector Commentary — As conflicts continue to smolder around the world, the gold price is rising but the true surge...
March 12, 2026 09:05 ET | Source: USA News Group

The Gold Mining Scene Continues to Shine Amid Conflict-Driven Price Surge

VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary — As global conflicts continue to grab attention around the world, the price of gold continues to...